Northern Plains Laboratory LLC

Northern Plains Laboratory LLC, a for-profit limited liability company and subsidiary of Pathology Consultants PC (a self-certified small disadvantaged business), provides reference laboratory testing, anatomical and hematopathology analyses, molecular diagnostics, and on-site pathology consultations to the Indian Health Service as a prime contractor, competing on a full and open basis with no set-aside designation.

The vendor's footprint centers almost exclusively on the Indian Health Service. Of 727 total awards across the past five years, 714 (98%) flow from IHS, representing $81.2 million in combined potential value. The remainder splits among the Department of the Army North Dakota Army National Guard (nine awards, $557 thousand), the Department of the Army (two awards, $153 thousand), and minimal exposure to the Department of Veterans Affairs and the Centers for Disease Control and Prevention. The concentration is extreme: IHS accounts for 99% of the vendor's contract dollars.

Northern Plains Laboratory operates as a single-award prime contractor under two primary IHS vehicles. Contract 75H70623D00014, awarded May 23, 2023, with a ceiling of $18.4 million through March 4, 2027, supports twelve IHS healthcare facilities across the Great Plains region in South Dakota, North Dakota, and Nebraska—Belcourt Hospital, Fort Yates IHS Hospital, Pine Ridge Indian Health Service Unit, Cheyenne River Health Center (Eagle Butte), Rosebud IHS Hospital, Lower Brule IHS Healthcare Center, Fort Thompson Indian Health Service, Sisseton Service Unit, Standing Rock Service Unit (McLaughlin and Fort Yates), Wagner IHS Healthcare Center, and Browning's BFSU Laboratory. This vehicle alone generated 159 task orders valued at $16.3 million. A predecessor IDIQ (HHSI241201800004I), valued at $18.4 million, generated 434 task orders at $18.4 million combined potential value—indicating a production pattern of numerous small delivery orders (typically $25,000 to $300,000 per task order) issued monthly across the facility network to cover rolling testing and consultation needs.

Recent representative awards illustrate the work: a $406,017 task order (July 2025) for reference laboratory testing and pathology site visits at Pine Ridge, Kyle, and Wanblee health centers; a $445,929 delivery order (April 2026) for the same three facilities; a $241,912 order (August 2026) for Rosebud; and a $150,834 order (October 2026) for Belcourt Hospital. Task order ceilings range from approximately $12,000 to $445,000. Northern Plains Laboratory delivers all services directly—the source identifies no subcontractors—and maintains no presence on parent GWACs, agency-wide IDIQs, or other multi-award vehicles. The Army awards ($557 thousand ND Army National Guard, $153 thousand Army) represent marginal exposure; a $50,000 purchase order from the Army (April 2026) for lab testing services with a five-year option period through March 2031 is the only non-IHS contract of scale.

Activity has declined slightly: 57 awards in 2022, peaking at 70 in 2023, then dropping to 55 in 2024, 41 in 2025, and 23 through October 2026—a pattern consistent with the transition from a predecessor IDIQ to the newer 75H70623D00014 vehicle. Combined potential value across all 727 awards totals $82 million, with $39.9 million (49%) obligated to date. A recompete cliff of $2.1 million in combined potential value hits within the next twenty-four months on fourteen awards, primarily closeout and de-obligate modifications to existing task orders.

The vendor is also a sub-recipient on a Centers for Disease Control and Prevention grant: the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), funded through the North Dakota Department of Health and Human Services as prime grantee, with a September 2023 sub-award. Northern Plains Laboratory operates from Bismarck, North Dakota, and its parent Pathology Consultants PC holds the small disadvantaged business designation that anchors the vendor's capacity claim in federal procurement.